Delivery Order SPE2DU25D9418-SPE2DU26FEPHC

The Defense Logistics Agency awarded a $75,221.82 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The order represents one of numerous delivery orders DMS Pharmaceutical Group has received under its broader Indefinite Delivery Contract with the Defense Logistics Agency.

This delivery order falls under DMS Pharmaceutical Group's single-award IDC with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR and valued at $499,999,999 through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide Department of Defense healthcare facilities worldwide with a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, vaccines, and medical consumables. As a regional prime vendor contractor under this framework, DMS Pharmaceutical Group supplies critical pharmaceutical products to support military healthcare operations globally, with no identified subcontractor relationships in this award.